COVID-19, from infection to cancer

Main Article Content

Mohanna Khandan
Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran

Mohammad Amin Khazeei Tabari
Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran

Noosha Samieefar
Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Nima Rezaei
Tehran University of Medical Sciences, Tehran, Iran

Keywords

COVID-19, SARS-CoV-2, Cancer, Tumor markers

Downloads

Download data is not yet available.
Abstract 113 | PDF Downloads 79

References

(1) Tabari MAK, Khoshhal H, Tafazoli A, Khandan M, Bagheri A. Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic. Informatics in Medicine Unlocked. 2020;21:100458.
(2) Nepogodiev D, Bhangu A, Glasbey JC, Li E, Omar OM, Simoes JFF, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. The Lancet. 2020;396(10243):27-38.
(3) Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. The American journal of emergency medicine. 2020;38(7):1504-7.
(4) Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. The Lancet Neurology. 2020.
(5) Jyotsana N, King MR. The impact of COVID-19 on cancer risk and treatment. Cellular and Molecular Bioengineering. 2020:1-7.
(6) Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nature reviews Disease primers. 2019;5(1):1-21.
(7) Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 2020;395(10224):575-90.
(8) Purut YE, Giray B, Gurbuz E. Effect of the coronavirus pandemic on tumor markers. Journal of Medical Virology. 2021.
(9) Garg A, Seeliger B, Derda AA, Xiao K, Gietz A, Scherf K, et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. European journal of heart failure. 2021;23(3):468-75.
(10) Francescangeli F, De Angelis ML, Zeuner A. COVID-19: a potential driver of immune-mediated breast cancer recurrence? Breast Cancer Research. 2020;22(1):117.
(11) Yang J, Li H, Hu S, Zhou Y. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19. Aging. 2020;12(8):6518-35.

Article Sidebar

PDF
Published
Oct 26, 2022
DOI

Article Details

How to Cite

1.
Khandan M, Khazeei Tabari MA, Samieefar N, Rezaei N. COVID-19, from infection to cancer. Acta Biomed [Internet]. 2022 Oct. 26 [cited 2023 Feb. 27];93(5):e2022224. Available from: 12882
Issue
Vol. 93 No. 5 (2022)
Section
CORRESPONDENCE - SPECIAL COVID19
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)

1 2 > >>